Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.66 HKD | -1.62% | -2.92% | -0.30% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |